AU2012217630A1 - Compositions and improved soft tissue replacement methods - Google Patents

Compositions and improved soft tissue replacement methods Download PDF

Info

Publication number
AU2012217630A1
AU2012217630A1 AU2012217630A AU2012217630A AU2012217630A1 AU 2012217630 A1 AU2012217630 A1 AU 2012217630A1 AU 2012217630 A AU2012217630 A AU 2012217630A AU 2012217630 A AU2012217630 A AU 2012217630A AU 2012217630 A1 AU2012217630 A1 AU 2012217630A1
Authority
AU
Australia
Prior art keywords
compound
pharmaceutically acceptable
alkyl
optionally substituted
mpa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012217630A
Other languages
English (en)
Inventor
Wha-Bin Im
Guang-Liang Jiang
Dennis E. Van Epps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/193,744 external-priority patent/US8697056B2/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU2012217630A1 publication Critical patent/AU2012217630A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3666—Epithelial tissues other than skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3869—Epithelial tissues other than skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
AU2012217630A 2011-02-17 2012-02-16 Compositions and improved soft tissue replacement methods Abandoned AU2012217630A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161444078P 2011-02-17 2011-02-17
US61/444,078 2011-02-17
US13/193,744 US8697056B2 (en) 2010-08-19 2011-07-29 Compositions and soft tissue replacement methods
US13/193,744 2011-07-29
PCT/US2012/025412 WO2012112757A2 (en) 2011-02-17 2012-02-16 Compositions and improved soft tissue replacement methods

Publications (1)

Publication Number Publication Date
AU2012217630A1 true AU2012217630A1 (en) 2013-09-05

Family

ID=46673171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012217630A Abandoned AU2012217630A1 (en) 2011-02-17 2012-02-16 Compositions and improved soft tissue replacement methods

Country Status (5)

Country Link
EP (1) EP2675491A2 (pt)
AU (1) AU2012217630A1 (pt)
BR (1) BR112013021035A2 (pt)
CA (1) CA2827615A1 (pt)
WO (1) WO2012112757A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
EP2814510A1 (en) * 2012-02-16 2014-12-24 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013123274A1 (en) * 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
EP4129353A1 (en) * 2020-03-25 2023-02-08 Fukuoka University Agent to be used in intraocular membrane detachment surgery
CN114748682A (zh) * 2022-04-26 2022-07-15 深圳湾实验室 用于制备烧创伤敷料的组合物及其制剂和制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756911A (en) 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6199076B1 (en) 1996-10-02 2001-03-06 James Logan Audio program player including a dynamic program selection controller
TWI249520B (en) 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
US20080299213A2 (en) 1999-11-05 2008-12-04 Donald Kleinsek Augmentation and repair of spincter defects with cells including adipocytic cells
US6673285B2 (en) 2000-05-12 2004-01-06 The Regents Of The University Of Michigan Reverse fabrication of porous materials
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
MXPA03004623A (es) 2000-11-27 2003-09-05 Pfizer Prod Inc Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
ATE500218T1 (de) 2001-07-23 2011-03-15 Ono Pharmaceutical Co Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
US20040254230A1 (en) 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
EP1563846B1 (en) * 2002-10-10 2012-08-29 Ono Pharmaceutical Co., Ltd. Endogenous repair factor production promoters
US6875787B2 (en) 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
AU2003206922A1 (en) 2003-02-19 2004-09-09 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
JP4698596B2 (ja) 2003-04-10 2011-06-08 タフツ ユニバーシティー 濃縮された水性シルクフィブロイン溶液およびそれらの使用
US7972628B2 (en) 2003-10-01 2011-07-05 University Of Washington Porous biomaterials
BRPI0506983A (pt) 2004-01-20 2007-07-03 Allergan Inc composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
JPWO2006016695A1 (ja) 2004-08-10 2008-05-01 小野薬品工業株式会社 Ｅｐ４アゴニストを含有してなる高カリウム血症の予防および／または治療剤
FR2878444B1 (fr) 2004-11-30 2008-04-25 Corneal Ind Soc Par Actions Si Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
JP4985400B2 (ja) 2005-06-24 2012-07-25 大正製薬株式会社 プロスタグランジン誘導体
WO2007016545A2 (en) 2005-08-01 2007-02-08 The Regents Of The University Of Michigan Porous materials having multi-size geometries
WO2008063569A1 (en) * 2006-11-16 2008-05-29 Coapt Systems, Inc. Co-mixed human fat and gel suspension implant material
WO2008092860A1 (en) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
WO2008092861A1 (en) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
WO2008092862A1 (en) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Bicyclic derivatives as ep4 agonists
US20090317367A1 (en) 2007-02-21 2009-12-24 Cedars-Sinai Medical Center Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
EP2147672A4 (en) 2007-05-08 2011-11-02 Nat University Corp Hamamatsu University School Of Medicine CYTOTOXIC T CELL ACTIVATOR WITH AN EP4 AGONIST
GB0810615D0 (en) 2008-06-10 2008-07-16 Glaxo Group Ltd Novel pharmaceutical
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
FI20085839A0 (fi) * 2008-09-08 2008-09-08 Timo Ylikomi Menetelmiä ja välineitä pehmytkudosteknologiaan
US8697056B2 (en) * 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods

Also Published As

Publication number Publication date
CA2827615A1 (en) 2012-08-23
WO2012112757A3 (en) 2014-01-09
WO2012112757A2 (en) 2012-08-23
BR112013021035A2 (pt) 2016-10-11
EP2675491A2 (en) 2013-12-25

Similar Documents

Publication Publication Date Title
US9334262B2 (en) Methods of treating soft tissue defects
US8883139B2 (en) Compositions and soft tissue replacement methods
US9005605B2 (en) Compositions and soft tissue replacement methods
US8926963B2 (en) Compositions and soft tissue replacement methods
US8900571B2 (en) Compositions and soft tissue replacement methods
US8741281B2 (en) Compositions and soft tissue replacement methods
US8894992B2 (en) Compositions and soft tissue replacement methods
US8889123B2 (en) Compositions and soft tissue replacement methods
US8697059B2 (en) Compositions and soft tissue replacement methods
US10300169B2 (en) Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
AU2012217630A1 (en) Compositions and improved soft tissue replacement methods
EP1263931A2 (en) Augmentation and repair of age-related soft tissue defects
WO2008070893A1 (en) Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system
CN107929809A (zh) 一种可注射的脱细胞小肠黏膜下层基质微粒及其制备方法与应用
WO2013123270A1 (en) Compositions and improved soft tissue replacement methods
WO2013123275A1 (en) Compositions and improved soft tissue replacement methods
WO2013123272A1 (en) Compositions and improved soft tissue replacement methods
WO2013123274A1 (en) Compositions and improved soft tissue replacement methods
WO2013105997A2 (en) Compositions and improved soft tissue replacement methods

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted